This is consistent with numerous documentations that the severity of cognitive impairments are associated with the degree of methylation mosaicism and FMRP expression in individuals with FXS [9,10,11,12], suggesting a progressive FMRP deficit leading to cognitive impairments. The gene discussed is FMR1; the disease is fragile X syndrome.